Document is current
Any future updates will be listed below
-
Authors
Zhang, Mu-Chen
Fang, Ying
Wang, Li
Cheng, Shu
Fu, Di
He, Yang
Zhao, Yan
Wang, Chao-Fu
Jiang, Xu-Feng
Song, Qi
Xu, Peng-Peng
Zhao, Wei-Li https://orcid.org/0000-0003-1704-4491
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81520108003, 81830007, 81670176)
Changjiang Scholar Program of Chinese Ministry of Education
Shanghai Municipal Education Commission (20152206, 20152208)
Shanghai Hospital Development Center (16CR2017A)
Multicenter Clinical Research Project by Shanghai Jiao Tong University School of Medicine (DLY201601)
Collaborative Innovation Center of Systems Biomedicine
Samuel Waxman Cancer Research Foundation
- License Information
-
More Information
Article History
Received: 31 March 2020
Accepted: 13 October 2020
First Online: 23 October 2020
Ethics approval and consent to participate
: The final protocol, amendments, informed consent, and any other appropriate documents were reviewed and approved by the ethics committee and institutional review board of Shanghai Ruijin Hospital (Reference Number 2016-24). Trial registration: ClinicalTrial.gov, NCT02753647. Registered on April 28, 2016,. The study was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all patients prior to enrollment.
: Not applicable.
: All authors declare that they have no competing interests.
